Relay Therapeutics
RLAY
$6.66
Share price
2.15%
Change (1 day)
-41.78%
Change (1 year)
Categories
P/S ratio for Relay Therapeutics (RLAY)
P/S ratio as of May 2024 (TTM): 33.8
According to Relay Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 33.7753. At the end of 2023 the company had a P/S ratio of 53.1.
P/S ratio history for Relay Therapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 53.1 | -95.94% |
| 2022 | > 1000 | 19.39% |
| 2021 | > 1000 | 2321.04% |
| 2020 | 45.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |